These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 2308984)
1. Persistent suppression of granulo-erythropoietic precursor cells in alpha interferon treated CML patients undergoing autologous stem cell transplantation: in vitro and clinical results. De Fabritiis P; Sandrelli A; Meloni G; De Felice L; Di Matteo G; Alimena G; Montefusco E; Defazio D; Mandelli F Prog Clin Biol Res; 1990; 333():225-33. PubMed ID: 2308984 [No Abstract] [Full Text] [Related]
2. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia. Wandl UB; Niederle N; Kranzhoff M; Seeber S Int J Cell Cloning; 1992 Sep; 10(5):292-8. PubMed ID: 1453016 [TBL] [Abstract][Full Text] [Related]
3. CML: new biologic therapies, endpoints and questions. Martin A; Cheson BD Oncology (Williston Park); 1987 Sep; 1(7):12-3, 16. PubMed ID: 3152809 [No Abstract] [Full Text] [Related]
4. Activity of alpha-interferons in chronic myelogenous leukaemia. Talpaz M Br J Clin Pract Suppl; 1988 Mar; 62():13-5. PubMed ID: 3145008 [No Abstract] [Full Text] [Related]
6. Collection of Ph-negative progenitor cells from Ph+ CML patients in complete cytogenetic remission after long-term interferon-alpha therapy. Russo D; Martinelli G; Montefusco V; Amabile M; Rosti G; Marin L Haematologica; 1999 Oct; 84(10):953-5. PubMed ID: 10509048 [No Abstract] [Full Text] [Related]
7. Interferon alpha-2a to control thrombocytosis in chronic myelogenous leukemia and essential thrombocythemia. Jootar S Asian Pac J Allergy Immunol; 1989 Dec; 7(2):103-5. PubMed ID: 2624663 [TBL] [Abstract][Full Text] [Related]
8. Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b. Freund M; von Wussow P; Knüver-Hopf J; Mohr H; Pohl U; Exeriede G; Link H; Wilke HJ; Poliwoda H Blut; 1988 Nov; 57(5):311-5. PubMed ID: 3196882 [TBL] [Abstract][Full Text] [Related]
9. [The treatment of chronic myeloid leukemia in chronic phase with interferons]. Guilhot F Pathol Biol (Paris); 1988 Dec; 36(10):1179-81. PubMed ID: 3070457 [No Abstract] [Full Text] [Related]
10. Clonality studies in CML patients treated by IFN and/or autologous bone marrow transplantation. Lo Coco F; Guerrasio A; Diverio D; Mandelli F; Saglio G Bone Marrow Transplant; 1994; 14 Suppl 3():S21-4. PubMed ID: 7697005 [No Abstract] [Full Text] [Related]
11. Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia. Estrov Z; Talpaz M; Chou TC; Kurzrock R; Blake M; Gutterman JU Leukemia; 1991 Feb; 5(2):101-7. PubMed ID: 2020193 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutic prospects of interferon in patients with chronic myelocytic leukemia]. Podsiadło Z; Skotnicki AB; Blicharski J Przegl Lek; 1988; 45(9):687-9. PubMed ID: 3075051 [No Abstract] [Full Text] [Related]
13. CML may not be part of HUS. Lipton JH; Minden M Am J Hematol; 1995 May; 49(1):100-1. PubMed ID: 7741131 [No Abstract] [Full Text] [Related]
14. Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantation. Borgies P; Ferrant A; Delannoy A; Van den Berghe H; Michaux JL Bone Marrow Transplant; 1989 Jan; 4(1):127-8. PubMed ID: 2647178 [TBL] [Abstract][Full Text] [Related]
15. Autografting for CML--overview and perspectives. Goldman JM Bone Marrow Transplant; 1996 May; 17 Suppl 3():S71-4. PubMed ID: 8769708 [No Abstract] [Full Text] [Related]
16. Autologous bone marrow transplantation in chronic myeloid leukaemia. Divya Natl Med J India; 1998; 11(1):19-21. PubMed ID: 9557515 [No Abstract] [Full Text] [Related]